Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Brisbane Angels is a prominent Australian angel investment group that provides seed and early-stage capital to high-growth potential startups. Established in 2006 and based in Brisbane, the group comprises over 100 high-net-worth investors who offer not only funding but also mentorship and strategic industry connections. While the group is sector-agnostic, it maintains a robust portfolio in the life sciences, biotechnology, and medical technology sectors, having backed notable Australian success stories. Brisbane Angels typically invests in companies that have moved beyond the concept stage and are seeking capital to scale their operations or clinical development. The group plays a critical role in the Australian innovation ecosystem by bridging the funding gap between initial seed rounds and larger venture capital investments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Brisbane Angels.